INNOCENTI, CHIARA

INNOCENTI, CHIARA  

Mostra records
Risultati 1 - 13 di 13 (tempo di esecuzione: 0.025 secondi).
Titolo Data di pubblicazione Autore(i) File
CMV AND EBV REACTIVATION AFTER AUTOLOGOUS HAEMOPOIETIC STEM CELL TRANSPLANTATION WITH BEAM CONDITIONING REGIMEN FOR MULTIPLE SCLEROSIS AND LYMPHOMA: A RETROSPECTIVE SINGLE CENTER CASE-CONTROL STUDY 2014 Di Gioia, M; Innocenti, C; Donnini, I; Nozzoli, C; Bosi, A; Guidi, S; Rigacci, L; Repice, A; Massacesi, L; Portaccio, E; Amato, MP; Saccardi, R
Efficacy of autologous hematopoietic stem cell transplantation in secondary progressive Multiple sclerosis 2019 Mariottini, A; Filippini, S; Di Tullio, MG; Forci, B; Innocenti, C; Barilaro, A; Fani, A; Saccardi, R; Massacesi, L; Repice, AM
Impact of autologous haematopoietic stem cell transplantation on disability and brain atrophy in secondary progressive multiple sclerosis 2021 Mariottini A.; Filippini S.; Innocenti C.; Forci B.; Mechi C.; Barilaro A.; Fani A.; Carlucci G.; Saccardi R.; Massacesi L.; Repice A.M.
Impact of new DMAs on the safety profile of patients undergoing autologous haematopoietic stem cell transplantation for Multiple Sclerosis 2016 Innocenti, C; Barilaro, A; Fani, A; Mariottini, A; Massacesi, L; Repice, AM; Saccardi, R
intermediate intensity regimen in autologous HSCT for severe Multiple Sclerosis: a a large, single center experience 2016 Saccardi, R; Barilaro, A; Fani, A; Giannini, M; Gozzini, A; Guidi, S; Innocenti, C; Mariottini, A; Nozzoli, C; Portaccio, E; Repice, AM; Amato, MP; Massacesi, L
Intermediate intensity regimen in autologous HSCT for severe multiple sclerosis: a large, single center experience 2016 Saccardi, R; Repice, AM; Innocenti, C; Mariottini, A; Amato, MP; Guidi, S; Fani, A; Nistri, R; Giannini, M; Portaccio, E; Barilaro, A; Nozzoli, C; Gozzini, A; Massacesi, L
Long-Term Clinical Outcomes of Hematopoietic Stem Cell Transplantation in Multiple Sclerosis 2021 Boffa, Massacesi L, Inglese M, Mariottini A, Capobianco M, Moiola L, Amato MP, Cottone S, Gualandi F, De Gobbi M, Greco R, Scime R, Frau J, Zimatore GB, Bertolotto A, ComiG, Uccelli A, Signori A, Angelucci E, Innocenti C, Ciceri F, Repice AM, Sormani MP, R. Saccardi R, Mancardi GL, and the Italian BMT-MS study group
Management of viral reactivation in multiple sclerosis patients after autologous transplantation with BEAM/ATG conditioning regimen 2019 Innocenti, C; Di Gioia, M; Amato, MP; Ciccone, N; Cutini, I; Giannini, M; Gozzini, A; Guidi, S; Mariottini, A; Massacesi, L; Nozzoli, C; Repice, A; Maria, RG; Saccardi, R
Purely myeloablative conditioning regimen in aggressive multiple sclerosis: two case reports 2016 Innocenti, C; Barilaro, A; Fani, A; Mariottini, A; Massacesi, L; Repice, AM; Saccardi, R
Quale strategia per la gestione dell’anemia in corso di triplice terapia anti-HCV? 2013 E.Salomoni; F.Baragli; C.Innocenti; G.Corti
Reconstitution of natural or vaccination-driven immunity after aHSCT in multiple sclerosis 2018 Innocenti, C; Amato, MP; Barilaro, A; Bianchini, G; Capobianco, T; Calia, MA; Ceschini, R; Fani, A; Giannini, M; Gozzini, A; Guidi, S; Mariottini, A; Massacesi, L; Nozzoli, C; Repice, A; Rossolini, G; Saccardi, R
Safety profile of autologous haematopoietic stem cell transplantation following natalizumab therapy in aggressive forms of multiple sclerosis 2015 Mariottini, A; Innocenti, C; Repice, AM; Fani, A; Massacesi, L; Saccardi, R
Sustained disease remission in multiple sclerosis after autologous haematopoietic stem cell transplantation. The Italian experience 2017 Boffa, G; Sormani, MP; Repice, AM; Curro, D; Capobianco, M; Gualandi, F; Lo Re, M; De Gobbi, M; Innocenti, C; Capello, E; Mariottini, A; Forci, B; Uccelli, A; Barilaro, A; Cottone, S; Bertolotto, A; Saccardi, R; Mancardi, GL; Massacesi, L